W
BIIB icon

Wealthfront’s Biogen BIIB Stock Holding History

Wealthfront’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$2.84M Buy
8,036
+728
+10% +$251K 0.03% 95
2018
Q2 		$2.12M Buy
7,308
+2,403
+49% +$676K 0.02% 118
2018
Q1 		$1.34M Sell
4,905
-2,989
-38% -$928K 0.01% 192
2017
Q4 		$2.52M Buy
7,894
+2,011
+34% +$645K 0.03% 95
2017
Q3 		$1.84M Buy
5,883
+2,526
+75% +$748K 0.02% 120
2017
Q2 		$911K Buy
3,357
+220
+7% +$58.2K 0.01% 164
2017
Q1 		$858K Sell
3,137
-71
-2% -$20.1K 0.02% 144
2016
Q4 		$910K Sell
3,208
-1,144
-26% -$339K 0.02% 124
2016
Q3 		$1.36M Buy
4,352
+3,482
+400% +$1.03M 0.03% 82
2016
Q2 		$210K Sell
870
-1,833
-68% -$483K 0.01% 335
2016
Q1 		$704K Sell
2,703
-215
-7% -$56.8K 0.02% 109
2015
Q4 		$894K Sell
2,918
-203
-7% -$58.3K 0.03% 91
2015
Q3 		$911K Buy
3,121
+1,382
+79% +$456K 0.04% 86
2015
Q2 		$702K Buy
1,739
+173
+11% +$69.4K 0.03% 79
2015
Q1 		$661K Buy
1,566
+581
+59% +$229K 0.03% 64
2014
Q4 		$334K Buy
985
+65
+7% +$21K 0.02% 107
2014
Q3 		$304K Buy
920
+201
+28% +$66.3K 0.02% 93
2014
Q2 		$238K Buy
719
+127
+21% +$38.2K 0.02% 89
2014
Q1 		$183K Buy
+592
New +$188K 0.02% 62

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wealthfront's BIIB Position: Q3 2018 in Review

Wealthfront increased its Biogen (BIIB) stake by 10% in Q3 2018, buying an estimated $251K and bringing the position to 8,036 shares worth $2.84M. The position accounts for 0.03% of the portfolio, ranked #95.

Wealthfront first reported a position in BIIB in Q1 2014 and has held it in 19 quarters since. 1,146 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

  • Wealthfront held 8,036 shares of Biogen worth $2.84M as of Q3 2018.
  • Wealthfront bought 728 Biogen shares in Q3 2018, an estimated $251K.
  • Biogen made up 0.03% of Wealthfront's portfolio in Q3 2018, its #95 holding.
  • Wealthfront first reported a position in Biogen in Q1 2014 and has held it in 19 quarters since.
  • 1,146 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.